Navigation Links
NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur 'Rising Stars' Honorees
Date:7/15/2009

BEIJING, July 15 /PRNewswire/ -- New Enterprise Associates (NEA), a leading global venture capital firm, today announced that four of its China-based portfolio companies were named to the Zero2IPO 2009 Venture 50 list: CITIC Pharmaceuticals, LianLian Pay, LineKong and Novast Pharmaceuticals. Spanning consumer technology, financial services and pharmaceutical sectors, the range of companies selected underscore the growth potential within several key areas of focus for NEA's investing activities in China.

Another NEA portfolio company, UPG, was recently honored by China Entrepreneur magazine as one of the "2009 Rising Stars -- Top Emerging Companies with Most Growth Potential." UPG, which specializes in microfinance, was among 21 companies selected for this award.

"NEA congratulates the management and nearly 3000 employees at CITIC Pharmaceuticals, LianLian Pay, LineKong, Novast Pharmaceuticals and UPG on their well-deserved recognition," said Xiaodong Jiang, Managing Director of New Enterprise Associates (Beijing) Ltd. "These five technology and healthcare companies have thrived despite global economic slowdown and emerged as leaders in their respective sectors in China. We look forward to supporting them in every way possible as they continue to pursue a path of rapid growth."

The 2009 Zero2IPO Venture 50 honorees were announced at the China Venture Capital & Private Equity Semi-Annual Forum held in Beijing on July 9-10. Winners were selected by a judging panel of 69 partners at leading venture capital and private equity firms from a pool of thousands of leading companies nominated over three months.

"LianLian is honored to be the only payment company to receive the China Venture 50 award from Zero2IPO," said Dong Wen, CEO of LianLian Pay. "NEA has been a strong supporter of LianLian since our inception and has played an integral role in our
'/>"/>

SOURCE New Enterprise Associates
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Burrill Merchant Banking Advises Pfizer Inc. on Dermatology Portfolio Divestment
2. Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting
3. Triple-S Management Corporation Announces Execution of Definitive Agreement to Acquire Managed Care Portfolio of La Cruz Azul de Puerto Rico, Inc.
4. RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition
5. Haemonetics Bolsters Blood Bank Information Management Portfolio With Acquisition of Altivation Software
6. Best Practice Database Adds Research Highlighting the Value of Portfolio Management in Early-Stage Commercialization and Customer-Focused Software Quality Assurance
7. RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition
8. Grubb & Ellis Healthcare REIT Acquires 185,000 SF Wisconsin Medical Office Buildings Portfolio
9. ACORNs Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting
10. RoundTable Healthcare Partners Leads Portfolio Company Add-On Acquisition
11. Dannon(TM) Expands Probiotic Portfolio with New Activia(TM) Extensions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... through national AAD program ,, SCHAUMBURG, ... from melanoma, the deadliest form of skin cancer, ... treated, if caught early. That,s why thousands of ... screenings in their communities through the American Academy ... The program recently reached a milestone - two ...
(Date:12/16/2009)... -- For ages, people from around the world have ... soothing waters have a reputation that dates back over ... miracles. Now, with the introduction of two bath salt ... the legendary benefits of Dead Sea salt in their ... all-natural Dead Sea salt and essential oils - but ...
(Date:12/16/2009)... International, Inc. (OTC Bulletin Board: MZEI) ... Board of Medizone New Zealand Ltd., a joint ... 50% interest, agreed on December 14, 2009 to ... International all global marketing rights of the company,s ... Marshall said, "Time has eroded the relevance of ...
(Date:12/16/2009)... While many of the,pharma companies are struggling ... and inmarket drugs, MarketsandMarkets on the other ... players. These pharma,forecasting solutions are designed for ... phase,III. These have a substantial impact on ... strategy, manufacturing planning, sales force,promotion, and planning. ...
(Date:12/16/2009)... could improve care, but privacy a concern, doctors ... U.S. physicians support the use of electronic medical ... two new studies show. , One study of ... in Massachusetts found that 86 percent believed electronic ... of care, 70 percent thought it would reduce ...
Breaking Medicine News(10 mins):Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:Pros and Cons of Electronic Medical Records Weighed 2
... (NEWARK, N.J., Oct. 3,2007) Rutgers College of Nursing faculty ... of the Nurse Educator of the New York Times 2007 ... three practicing nurses and one nurse educator from hundreds of ... The winners will be featured in a special section in ...
... , WEDNESDAY, Oct. 3 (HealthDay News) -- Identifying a ... best chemotherapy for patients, U.S. research suggests. , "We ... likely to respond to standard first-line therapy and which ... second-line therapy, based on gene expression profiling," lead author ...
... The screen uses CT scans and is performed without ... new study supports the effectiveness of an innovative form ... sent through a patient,s colon. , When it ... so-called "virtual colonoscopy" is just as effective as the ...
... WEDNESDAY, Oct. 3 (HealthDay News) -- Drug-coated stents offered ... patients with blocked coronary arteries, a large Canadian study ... artery become blocked again after stent implant -- was ... getting drug-coated stents, 7.4 percent versus 10.7 percent. The ...
... WHNN radio personality,Bob Hughes, a well-known voice in the Saginaw ... is moving to Saginaw this,month. "My hearing became damaged ... the quality of my life has changed significantly since being,fitted ... Hearing,",says Hughes. "I am really enjoying my new ears." ...
... UNION CITY, Calif., Oct. 3 Abaxis, Inc.,(Nasdaq: ... point-of-care,blood chemistry analysis systems, announced today the launch ... conjunction with the Piccolo xpress(TM) point of,care analyzer. ... specifically for imaging and,radiology centers in the United ...
Other Medicine News:Health News:Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award 2Health News:Gene Tests Match Up Lung Tumors, Best Treatment 2Health News:'Virtual' Colonoscopy an Effective Option: Study 2Health News:'Virtual' Colonoscopy an Effective Option: Study 3Health News:Study Finds Benefits With Drug-Coated Stents 2Health News:Study Finds Benefits With Drug-Coated Stents 3Health News:WHNN's Bob Hughes Fitted With Hearing Aids by Mobile Care Hearing Clinic Now Serving Saginaw Area 2Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 2Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 3
(Date:12/16/2009)... 16 Optimer Pharmaceuticals, Inc. (Nasdaq: ... 28th Annual J.P. Morgan Healthcare Conference at the ... Wednesday, January 13, 2010. Michael N. Chang, Optimer,s ... 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time). ... audio webcast of this presentation will be accessible ...
(Date:12/16/2009)... 16 , ... Microplasmin Recruits a Total of Over,640 patients ... ThromboGenics NV (Euronext Brussels: THR), a ... of innovative treatments for eye,disease, vascular disease ... completed,the enrolment of the second Phase III ...
(Date:12/15/2009)... Inc., a global leader focused on improving blood collection, ... to provide blood centers with Alyx® system supplies needed ... filed yesterday against Fenwal by Haemonetics Corporation ( HAE). ... an advanced medical instrument used worldwide to collect two ... about 30 minutes. ,, Fenwal will ask ...
Breaking Medicine Technology:Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 3Ethiopias climate 27 million years ago had higher rainfall warmer soil 10491 1Ethiopias climate 27 million years ago had higher rainfall warmer soil 10491 2Syphilis survey reveals need for accurate testing for early infection 59960 1RIT scientist shines laser light on methane in pursuit of clean fuel 10490 1RIT scientist shines laser light on methane in pursuit of clean fuel 10490 2
... Computerized tomographic (CT),colonography, also known as virtual colonoscopy, ... flexible tube with a camera to view the,lining ... detect cancer and,precancerous polyps and could serve as ... the results of the American College of,Radiology Imaging ...
... Biotech has become,aware of preliminary data from an ... in patients with acute ischemic stroke. In,this study, ... with,Epoetin alfa within six hours of the onset ... placebo. Ortho Biotech has reported this,information to the ...
Other Medicine Technology:Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy 2Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy 3Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: